Search - tctmd.com

Displaying 221 - 240 of 613

Sort: Relevancy | Date

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

April 26, 2022

News Daily News

Intermittent Fasting Trial Rumbles Weight-Loss Landscape

Todd Neale

April 22, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Daily News

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Yael L. Maxwell

March 28, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

Advertisement

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Good News and Bad for High-Intensity Statin Use in ASCVD

May 2022 News Roundup

USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention

Intermittent Fasting Trial Rumbles Weight-Loss Landscape

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content